Morgan Stanley Apyx Medical Corp Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Apyx Medical Corp stock. As of the latest transaction made, Morgan Stanley holds 13,665 shares of APYX stock, worth $41,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,665

Previous 14,057 2.79%

Holding current value

$41,678

Previous $19,000 57.89%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$0.83 - $2.25 $325 - $882	-392 Reduced 2.79%	13,665 $30,000
Q1 2025 May 15, 2025	SELL	$1.0 - $1.72 $1,400 - $2,408	-1,400 Reduced 9.06%	14,057 $19,000
Q4 2024 Feb 14, 2025	SELL	$1.1 - $1.9 $424 - $733	-386 Reduced 2.44%	15,457 $24,000
Q3 2024 May 14, 2025	SELL	$1.01 - $1.46 $1,464 - $2,117	-1,450 Reduced 8.38%	15,843 $19,000
Q3 2024 Nov 14, 2024	SELL	$1.01 - $1.46 $1,464 - $2,117	-1,450 Reduced 8.38%	15,843 $19,000
Q2 2024 May 14, 2025	BUY	$1.26 - $1.66 $2,313 - $3,047	1,836 Added 11.88%	17,293 $23,000
Q2 2024 Oct 17, 2024	SELL	$1.26 - $1.66 $3,342 - $4,403	-2,653 Reduced 13.3%	17,293 $23,000
Q2 2024 Aug 14, 2024	SELL	$1.26 - $1.66 $3,342 - $4,403	-2,653 Reduced 13.3%	17,293 $23,000
Q1 2024 Oct 17, 2024	BUY	$1.25 - $2.71 $3,316 - $7,189	2,653 Added 15.34%	19,946 $27,000
Q1 2024 Aug 16, 2024	BUY	$1.25 - $2.71 $3,500 - $7,588	2,800 Added 16.33%	19,946 $27,000
Q1 2024 May 15, 2024	BUY	$1.25 - $2.71 $3,500 - $7,588	2,800 Added 16.33%	19,946 $27,000
Q4 2023 Aug 16, 2024	SELL	$1.49 - $3.25 $219 - $477	-147 Reduced 0.85%	17,146 $44,000
Q4 2023 Feb 13, 2024	SELL	$1.49 - $3.25 $1,877 - $4,095	-1,260 Reduced 6.85%	17,146 $44,000
Q3 2023 Nov 15, 2023	BUY	$3.07 - $6.2 $6,103 - $12,325	1,988 Added 12.11%	18,406 $58,000
Q2 2023 Aug 14, 2023	SELL	$2.75 - $7.59 $458,416 - $1.27 Million	-166,697 Reduced 91.03%	16,418 $82,000
Q1 2023 May 15, 2023	SELL	$2.45 - $3.59 $238,644 - $349,687	-97,406 Reduced 34.72%	183,115 $527,000
Q4 2022 Feb 14, 2023	BUY	$1.4 - $5.02 $330,437 - $1.18 Million	236,027 Added 530.47%	280,521 $656,000
Q3 2022 Nov 14, 2022	SELL	$4.49 - $10.83 $9,590 - $23,132	-2,136 Reduced 4.58%	44,494 $200,000
Q2 2022 Oct 27, 2022	BUY	$3.11 - $7.5 $88,426 - $213,247	28,433 Added 156.25%	46,630 $272,000
Q2 2022 Aug 15, 2022	BUY	$3.11 - $7.5 $88,426 - $213,247	28,433 Added 156.25%	46,630 $272,000
Q1 2022 Oct 27, 2022	SELL	$5.87 - $13.13 $166,901 - $373,325	-28,433 Reduced 60.98%	18,197 $119,000
Q1 2022 May 13, 2022	SELL	$5.87 - $13.13 $86,153 - $192,709	-14,677 Reduced 44.65%	18,197 $119,000
Q4 2021 Feb 14, 2022	SELL	$12.15 - $17.4 $269,353 - $385,740	-22,169 Reduced 40.28%	32,874 $422,000
Q3 2021 Nov 15, 2021	BUY	$8.79 - $13.96 $483,827 - $768,400	55,043 New	55,043 $762,000

Others Institutions Holding APYX

# of Institutions

Shares Held

17.6M

Call Options Held

50.1K

Put Options Held

View Full List

About Apyx Medical Corp

Ticker APYX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,573,000
Market Cap $105M
Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...

More about APYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account